Finally, prior studies (36) have shown that the seeding of tau pathology by exogenous tau fibrils can be inhibited by heparin, and we confirmed that heparin could reduce the extent of AD-tau seeded pathology in the neuronal assay (Fig. 1D). This evidence concerns the gene MAPT and Alzheimer disease.